Stevens P, Young L S, Hewitt W L
J Antibiot (Tokyo). 1976 Aug;29(8):829-32. doi: 10.7164/antibiotics.29.829.
A radioimmunoassay (RIA) has been developed using 125I-amikacin. Amikacin was iodinated by a modified BOLTON and HUNTER method. Dextran-charcoal was used to separate bound from free drug. The standard curve was linear on a logit-log plot in the range of 0.5 ng to 4 ng amikacin per tube. There was no cross-reactivity of amikacin antisera to the amino-glycosides gentamicin, tobramycin, netilmicin, and sisomicin but a 70% cross-reaction was observed with kanamycin, the compound from which amikacin is synthetically derived. Correlation of the RIA with a microbioassay for the determination of serum amikacin levels in 18 patient samples was excellent (r = 0.94). This new RIA technique is more sensitive, rapid, versatile, and less costly than the RIA using 3H-amikacin, and is far more sensitive and faster than microbioassay.
已开发出一种使用125I-阿米卡星的放射免疫分析法(RIA)。阿米卡星通过改良的博尔顿和亨特方法进行碘化。葡聚糖-活性炭用于分离结合型和游离型药物。在每管0.5纳克至4纳克阿米卡星的范围内,标准曲线在logit-log图上呈线性。阿米卡星抗血清与氨基糖苷类药物庆大霉素、妥布霉素、奈替米星和西索米星无交叉反应,但与合成阿米卡星的原料化合物卡那霉素有70%的交叉反应。对18份患者样本进行RIA与微生物测定法以测定血清阿米卡星水平的相关性极佳(r = 0.94)。这种新的RIA技术比使用3H-阿米卡星的RIA更灵敏、快速、通用且成本更低,并且比微生物测定法灵敏得多且速度更快。